Adiponectin Testing Market Share

  • Report ID: 4140
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Adiponectin Testing Market Share

North American Market Forecast   

North America industry is estimated to hold largest revenue share by 2037. The growth of the market can be attributed majorly to the rising cases of cardiometabolic diseases and a growing population with obesity. Data released by the Centers for Disease Control and Prevention demonstrated the fact that approximately 659,000 people lose their lives due to heart diseases annually solely in the United States. Furthermore, up-surged manufacturing of testing laboratories in the region is anticipated to boost the growth of the market in the region. Also, the increasing number of people suffering from being overweight, the rising population with type 2 diabetes, and other metabolic syndromes are estimated to boost the market growth. The increasing adoption of a high-calorie diet by most people with no physical activity or work is estimated to propel market growth. People prefer ready-to-eat food as it does not require much cooking time as people are busy in their work life. Rising stress, anxiety, and tension also increase blood pressure leading to cardiovascular disorders thereby increasing the market growth.

APAC Market Statistics

Furthermore, the Asia Pacific region is anticipated to represent lucrative opportunities for the growth of the market over the forecast period. The growth of the market in the region is ascribed to rising investments in healthcare R&D activities and a growing geriatric population with cardio metabolism and chronic diseases. Such factors are estimated to boost the growth of the market in the region over the forecast period.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4140
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of adiponectin testing is estimated at USD 2.7 billion.

The adiponectin testing market size was valued at USD 2.36 billion in 2024 and is set to exceed USD 6.9 billion by 2037, expanding at over 8.6% CAGR during the forecast period i.e., between 2025-2037. Increasing adoption of adipose-derived products and the higher prevalence of cardio-metabolic diseases globally will boost the market growth.

North America industry is estimated to hold largest revenue share by 2037, attributed to rising cases of cardiometabolic diseases and a growing population with obesity.

The major players in the market are STRATEC SE, Laboratory Corporation of America Holdings, Bio-Rad Laboratories, Inc., Boster Biological Technology, Thermo Fisher Scientific Inc., Eagle Biosciences, Inc., Merck KGaA, ERBA Diagnostics, Inc., Zeus Scientific Inc., Trinity Biotech plc
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample